What is the COVID-19 antibody blood test and should I get one?

What is a COVID-19 antibody test?

Put simply, a COVID-19 antibody blood test can be used to detect antibodies in your blood. Antibodies are part of the body's immune system and are created to defend the body when it detects potentially harmful infections (known as pathogens).

In terms of coronavirus (COVID-19), the presence of antibodies suggests either or both of the following:

• You have previously been infected with COVID-19.

• Your immune system has responded by making antibodies after having the COVID-19 vaccine.

All vaccinations work by injecting a person with a modified or inactivated virus, or part of the virus, that they want to be protected against. When the immune system first meets a virus, it takes time to produce enough antibodies to defend the body effectively.

However, immunisation results in the production of B cells (a form of white blood cells) which make antibodies specific to a given infection. By triggering the production of antibodies without making the host ill, vaccinations mean that if a person does get infected with the virus, the immune system jumps to a 'secondary' response, which is much quicker and better at fighting the illness.

In addition, both immunisation against and infection with COVID-19 results in the production of another type of immunity - T-cell immunity. T cells are a type of white blood cell which are largely effective at preventing severe disease, rather than initial infection. Protection from T cells usually lasts significantly longer than antibody immunity.

It's important to note that a COVID-19 antibody test will not tell you:

• If you are currently infected with COVID-19.

• Whether you can still catch and spread COVID-19.

• The level of your T cells specific to COVID-19.

COVID-19 infection survey data

Antibody testing is playing an important role over the COVID-19 pandemic. The Office for National Statistics (ONS) and Department for Health and Social Care (DHSC) release their Coronavirus (COVID-19) Infection Survey data on a fortnightly basis. These data provide important analysis on past infection and/or vaccination rates, based on randomly sampled subjects testing positive for antibodies.

How antibody swab testing can be useful

The COVID-19 Infection Survey is part of a major long-term study that tracks COVID-19 infections and vaccinations. It involves taking regular PCR swabs and antibody blood tests from over 596,000 volunteers across the UK, whether they have symptoms or not. This has helped to build a huge database that's used by scientists to better understand how COVID-19 immune response works.

Infection estimates

If a COVID-19 antibody test contributes to the national database, such as the COVID-19 Infection Survey, then it helps to improve estimations of the spread of past infections as well as response to vaccination.

There remains a very big difference between the number of people testing positive and the actual number of people who have been infected. For instance, in the week ending 1st December 2021, the COVID-19 Infection Survey results showed 1.056 million were likely to have been infected that week. In the same week, 363,682 people had symptoms, took a PCR test and tested positive - three times fewer than the actual number of infections. More antibody testing helps to close this gap in understanding.

Vaccination estimates

By testing for COVID-19 antibodies, the COVID-19 Infection Survey is also painting a picture of the vaccination uptake and effectiveness. This includes estimates for how many vaccination doses a percentage of the general population has had in England. The survey has already shown a clear pattern between vaccination and testing positive for COVID-19 antibodies.

"We continue to see a high level of antibodies across the UK. This is likely the impact of the booster programme on our data, with age groups prioritised for boosters seeing increases in antibody levels," says Dr Rhiannon Yapp, senior statistician.

Patient picks for COVID-19

Chest and lungs

COVID-19: Is Omicron a bigger threat than the Delta variant?

It has been less than three weeks after scientists in South Africa and Botswana sounded the alarm over a concerning new strain of COVID-19. Since then, the Omicron variant has spread quickly, leading to a speeding up of the booster vaccination programme in the UK. But is the Omicron variant a bigger threat than previous strains - and what do we know about it so far?

by Lydia Smith

Chest and lungs

Long COVID

Most people with COVID-19 infection (SARS CoV-2 infection) feel better within a few days or weeks and recover completely within 12 weeks of the infection. However, some people have ongoing symptoms that remain for weeks, months, or longer, which is usually called "long COVID". For some, these long-term effects of COVID-19 can be debilitating. These effects can be very different from person to person, and it seems likely that there are different 'types' of long COVID, or different syndromes, which might behave in different ways.

by Dr Doug McKechnie, MRCGP

Benefits of the London Medical Laboratory COVID-19 Antibody Blood Test

The London Medical Laboratory's COVID-19 Vaccine and Immune Response - "Quantitative" Antibody Blood Test can be used at home or in-store, and measures the level of immunoglobulin G (IgG) antibodies in your body.

Receiving a positive result means that the test has detected an arbitrary units per millilitre (AU/ml) level of above 50 units, suggesting that you have either been exposed to COVID-19 or that your body has produced an immune response to the vaccine.

This said, it is possible to have an immune response with a lower level of antibodies than this. Therefore, a negative result does not mean that you haven't been infected or that your vaccination hasn't worked. Whether you receive a positive or a negative result, it's important to note that the COVID-19 antibody test doesn't paint a full picture of your immunity.

However, it is thought that 1 in 100 people don't produce antibodies after the COVID-19 vaccination. Dr Quinton Fivelman, chief medical officer at London Medical Laboratory, also highlights that: "Recent research has shown that the early immune response in people who have been vaccinated for COVID-19 can predict the level of protection they will have to the virus over time."

A positive result from the COVID-19 antibody test kit can confirm if you have produced detectable antibodies in response to the vaccine. Most importantly, this can provide you with peace of mind to know you have some level of protection through them.

Limitations of the London Medical Laboratory COVID-19 Antibody Blood Test

While testing positive for antibodies can provide you with peace of mind, testing negative is not a reason to panic about your immune protection against COVID-19.

Professor Rodney E. Rohde, a professor of clinical laboratory science and an infectious disease specialist at Texas State University, stresses that anyone who chooses to take an antibody test "truly needs to 'understand' what these results might mean".

Antibodies are not a precise measure of immunity

It's important to draw the distinction between having immunity against COVID-19 and testing positive for IgG antibodies. Antibody levels can vary from person to person and having levels below an AU/ml level of above 50 units is not the same as having no immune protection.

"A low level of IgG may also not mean one it not completely vulnerable to the virus. The test does not measure T-cell activity and other forms of protection," says Rohde.

Both B cells and T cells (known as lymphocytes) are involved in our immune response to infections. B cells produce antibodies, whereas T cells directly attack the invading pathogen and are associated with longer-term immunity.

It is also not yet known how long antibodies last or how long your IgG levels remain high after infection or vaccination, and research into this is ongoing.

These measurements may not be suitable for all virus variants

The London Medical Laboratory COVID-19 antibody test is a quantitative measurement of IgG antibodies against the spike receptor binding domain (RBD) of COVID-19. The RBD is the part of the virus that allows it to lock on to body receptors to gain entry into body cells. Rohde advises that this specific binding domain may not be the best measurement for future COVID-19 variants, such as when we learn more about Omicron.

At-home sampling errors

At-home test kits can be convenient, but Rohde also points out that sampling errors can occur if instructions are not followed as stated. Research studies have shown that most laboratory errors occur in the pre-analytical phase (the collection and storage of the blood tests).

Use of data for research

While a COVID-19 antibody test for the ONS/DHSC Infection Survey feeds into a database that scientists can access in order to gain greater understanding of COVID-19 immunity, private test kit results are not available for scientific research. This is, however, an area that London Medical Laboratory is looking into.

For now, the benefit of ordering an antibody test for COVID-19 will be for your own peace of mind and curiosity.